Butofilolol
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Systematic (IUPAC) name | |
---|---|
(RS)-1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one
|
|
Identifiers | |
CAS Number | 64552-17-6 N |
ATC code | none |
PubChem | CID: 68838 |
ChemSpider | 62071 Y |
UNII | 4AZC6Y5A8G Y |
ChEMBL | CHEMBL157443 Y |
Synonyms | CM-6805 |
Chemical data | |
Formula | C17H26FNO3 |
Molecular mass | 311.392 g/mol |
|
|
|
|
NY (what is this?) (verify) |
Butofilolol (trade name Cafide) is a beta-blocker drug for the treatment of essential hypertension (high blood pressure).[1][2] It is not known to be marketed anywhere.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
<templatestyles src="Asbox/styles.css"></templatestyles>
40px |
This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "https://infogalactic.com/w/index.php?title=Butofilolol&oldid=2054779"
Categories:
- Pages with reference errors
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Beta blockers
- Pages with broken file links
- Antihypertensive agent stubs